Cargando…
Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Science
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187833/ https://www.ncbi.nlm.nih.gov/pubmed/32361326 http://dx.doi.org/10.1016/j.jcv.2020.104388 |
| _version_ | 1783527233124564992 |
|---|---|
| author | Fleming, Andrew B. Raabe, Vanessa |
| author_facet | Fleming, Andrew B. Raabe, Vanessa |
| author_sort | Fleming, Andrew B. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7187833 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71878332020-04-28 Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement Fleming, Andrew B. Raabe, Vanessa J Clin Virol Article Elsevier Science 2020-06 2020-04-28 /pmc/articles/PMC7187833/ /pubmed/32361326 http://dx.doi.org/10.1016/j.jcv.2020.104388 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Fleming, Andrew B. Raabe, Vanessa Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement |
| title | Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement |
| title_full | Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement |
| title_fullStr | Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement |
| title_full_unstemmed | Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement |
| title_short | Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement |
| title_sort | current studies of convalescent plasma therapy for covid-19 may underestimate risk of antibody-dependent enhancement |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187833/ https://www.ncbi.nlm.nih.gov/pubmed/32361326 http://dx.doi.org/10.1016/j.jcv.2020.104388 |
| work_keys_str_mv | AT flemingandrewb currentstudiesofconvalescentplasmatherapyforcovid19mayunderestimateriskofantibodydependentenhancement AT raabevanessa currentstudiesofconvalescentplasmatherapyforcovid19mayunderestimateriskofantibodydependentenhancement |